A Tirzepatide Injection Once Weekly for the Treatment of Obesity

Tirzepatide – commonly known as Mounjaro™ – is FDA-approved for controlling diabetes similar to Semaglutide (also known as Ozempic®/Wegovy™). During clinical studies it has been shown the efficacy of Tirzepatide for weight loss.

In obesity cases the active ingredient Tirzepatide is being prescribed by doctors off-label for weight loss. Tirzepatide produces weight loss by stimulating two satiety hormone receptors instead of just one with Semaglutide.